BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33161837)

  • 21. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer.
    Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
    Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
    Sun M; Qiu J; Zhai H; Wang Y; Ma P; Li M; Chen B
    Med Sci Monit; 2020 Aug; 26():e924604. PubMed ID: 32740646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer.
    Song L; Wang XY; He XF
    Med Sci Monit; 2019 Aug; 25():6313-6320. PubMed ID: 31422414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
    Chen W; Lin Y; Huang J; Yan Z; Cao H
    J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X; Zhang Z; Zhang L; Zhou L
    Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
    Zhao R; Zhao L; Xu X; Xu H
    Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a novel prognostic signature in gastric adenocarcinoma.
    Mao R; Wang Z; Zhang Y; Chen Y; Liu Q; Zhang T; Liu Y
    Aging (Albany NY); 2020 Nov; 12(21):22233-22252. PubMed ID: 33188157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.